We are live on
!
Find out more
6M
6 Meridian Portfolio holdings
AUM
$1.37B
Turnover
15.9%
1-Year Est. Return
17.3%
This Fund
S&P 500
This Quarter
Est. Return
+3.47%
1 Year Est. Return
+17.3%
3 Year Est. Return
+45.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$957M
AUM Growth
+$13.3M
(+1.4%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
57.22%
Holding
420
New
81
Increased
54
Reduced
131
Closed
154
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETC 6 Meridian Hedged Equity Index Option ETF
SIXH
|
+$12.7M |
| 2 |
Pfizer
PFE
|
+$8.14M |
| 3 |
ETC 6 Meridian Low Beta Equity ETF
SIXL
|
+$6.42M |
| 4 |
ETC 6 Meridian Mega Cap Equity ETF
SIXA
|
+$6.06M |
| 5 |
Walgreens Boots Alliance
WBA
|
+$5.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$6.67M |
| 2 |
Caterpillar
CAT
|
+$6.08M |
| 3 |
Duke Energy
DUK
|
+$5.51M |
| 4 |
Exelon
EXC
|
+$5.06M |
| 5 |
AT&T
T
|
+$4.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 80.58% |
| 2 | Healthcare | 4.92% |
| 3 | Consumer Staples | 4.11% |
| 4 | Financials | 2.86% |
| 5 | Technology | 2.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
ETC 6 Meridian Hedged Equity Index Option ETF
SIXH
$614M
| $193M | 20.15% |
7,394,002
+492,121
| +7% | +$12.7M |
2020 Q2
1 quarter
|
|
|
2
ETC 6 Meridian Mega Cap Equity ETF
SIXA
$547M
| $106M | 11.05% |
3,813,101
+220,569
| +6% | +$6.06M |
2020 Q2
1 quarter
|
|
|
3
ETC 6 Meridian Low Beta Equity ETF
SIXL
$202M
| $84.1M | 8.79% |
3,137,034
+236,205
| +8% | +$6.42M |
2020 Q2
1 quarter
|
|
4
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $41.5M | 4.33% |
816,114
+27,231
| +3% | +$1.38M |
2018 Q4
7 quarters
|
|
5
Vanguard Short-Term Treasury ETF
VGSH
$35.1B
| $28.4M | 2.96% |
456,691
+30,494
| +7% | +$1.89M |
2019 Q4
3 quarters
|
|
6
ETC 6 Meridian Small Cap Equity ETF
SIXS
$141M
| $22.9M | 2.4% |
780,777
+77,526
| +11% | +$2.3M |
2020 Q2
1 quarter
|
|
7
Invesco Variable Rate Investment Grade ETF
VRIG
$1.87B
| $20.6M | 2.15% |
827,025
+46,587
| +6% | +$1.15M |
2020 Q1
2 quarters
|
|
8
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.66B
| $20M | 2.09% |
394,787
+24,809
| +7% | +$1.26M |
2019 Q4
3 quarters
|
|
9
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.46B
| $16.1M | 1.68% |
311,788
+20,231
| +7% | +$1.05M |
2020 Q1
2 quarters
|
|
10
State Street SPDR S&P China ETF
GXC
$445M
| $15.4M | 1.61% |
129,840
-3,593
| -3% | -$423K |
2017 Q4
11 quarters
|
|
11
Vanguard FTSE Europe ETF
VGK
$29.7B
| $14M | 1.47% |
267,345
-9,330
| -3% | -$498K |
2017 Q4
11 quarters
|
|
12
Janus Henderson Short Duration Income ETF
VNLA
$3.56B
| $12.5M | 1.3% |
247,613
+15,677
| +7% | +$790K |
2020 Q1
2 quarters
|
|
13
iShares MSCI Japan ETF
EWJ
$23.2B
| $11.1M | 1.16% |
187,261
-6,539
| -3% | -$374K |
2017 Q4
11 quarters
|
|
14
Vanguard FTSE Pacific ETF
VPL
$8.55B
| $10.6M | 1.11% |
156,463
-5,615
| -3% | -$375K |
2017 Q4
11 quarters
|
|
|
15
Pfizer
PFE
$168B
| $8.08M | 0.84% |
+232,067
| New | +$8.14M |
2020 Q3
0 quarters
|
|
16
Target
TGT
$71.2B
| $8.02M | 0.84% |
50,949
+13,058
| +34% | +$1.79M |
2018 Q1
10 quarters
|
|
17
Verizon
VZ
$184B
| $7.79M | 0.81% |
130,879
-36,849
| -22% | -$2.14M |
2018 Q1
10 quarters
|
|
18
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $7.53M | 0.79% |
67,943
+615
| +0.9% | +$69.1K |
2020 Q1
2 quarters
|
|
19
Biogen
BIIB
$34.8B
| $7.02M | 0.73% |
24,742
+19,870
| +408% | +$5.54M |
2020 Q2
1 quarter
|
|
20
AbbVie
ABBV
$501B
| $5.99M | 0.63% |
68,338
+31,082
| +83% | +$2.93M |
2019 Q4
3 quarters
|
|
21
iShares MSCI Canada ETF
EWC
$7.28B
| $5.97M | 0.62% |
217,791
-7,419
| -3% | -$205K |
2017 Q4
11 quarters
|
|
22
iShares MSCI United Kingdom ETF
EWU
$3.77B
| $5.68M | 0.59% |
222,702
-6,092
| -3% | -$160K |
2017 Q4
11 quarters
|
|
23
iShares MSCI Taiwan ETF
EWT
$11.9B
| $5.66M | 0.59% |
126,010
-3,487
| -3% | -$154K |
2017 Q4
11 quarters
|
|
24
iShares MSCI South Korea ETF
EWY
$22.3B
| $5.64M | 0.59% |
86,296
-2,395
| -3% | -$150K |
2017 Q4
11 quarters
|
|
25
Invesco CEF Income Composite ETF
PCEF
$761M
| $5.49M | 0.57% |
271,361
-9,269
| -3% | -$191K |
2017 Q4
11 quarters
|
|
Similar funds
RFA
CCT
NFG
TU
C
CC
RM
EC
6 Meridian's Q3 2020 Portfolio in Review
As of Q3 2020, 6 Meridian held 420 positions worth $957M, up 1.4% from $943M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
6 Meridian's Q3 2020 filing shows 81 new, 54 increased, 131 reduced and 154 closed positions. Its largest new stake was Pfizer: 232,067 shares worth $8.08M. The largest sale was Southern Company, an estimated $6.67M.
By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 76% a quarter earlier, followed by Healthcare and Consumer Staples.
- 6 Meridian's largest Q3 2020 buy was Pfizer: 232,067 shares worth $8.08M.
- 6 Meridian added most to ETC 6 Meridian Hedged Equity Index Option ETF in Q3 2020, an estimated $12.7M increase.
- 6 Meridian's biggest Q3 2020 reduction was AT&T, cutting an estimated $4.52M.
- 6 Meridian fully exited Southern Company in Q3 2020, selling an estimated $6.67M.
- 6 Meridian's ten largest holdings make up 57% of its $957M portfolio in Q3 2020.
- 6 Meridian opened 81 new positions and closed 154 in Q3 2020.
- 6 Meridian's portfolio value rose 1.4% quarter-over-quarter to $957M.
Based on 6 Meridian's 13F filing for Q3 2020, filed 19 Oct 2020.